Nose Diseases  >>  mometasone furoate nasal spray  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mometasone furoate nasal spray / Generic mfg.
NCT01920893 / 2013-001803-35: An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis

Checkmark In nasal polyposis and chronic sinusitis at AAAAI 2017
Mar 2017 - Mar 2017: In nasal polyposis and chronic sinusitis at AAAAI 2017
Checkmark
Feb 2016 - Feb 2016: 
Checkmark At EAACI 2015
More
Completed
2
60
US, Europe
Placebo (for dupilumab), Dupilumab, SAR231893, REGN668, Mometasone furoate nasal spray, NASONEX®
Sanofi, Regeneron Pharmaceuticals
Nasal Polyps
11/14
11/14
NCT01523236: Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

Completed
1/2
800
US
Mometasone furoate, Nasonex®, Mometasone furoate (generic name), Placebo
Teva Pharmaceuticals USA
Seasonal Allergic Rhinitis
01/12
01/12

Download Options